ESP PHARMA
ESP Pharma is a hospital-focused pharmaceutical company, engages in acquiring and enhancing the marketing of approved specialty therapeutics and late-stage development drugs. It provides therapeutics to physicians, hospitals, and acute-care patients. ESP produces drugs for acute-care hospital use. Its drugs include therapeutics for high blood pressure and angina.
ESP PHARMA
Social Links:
Industry:
Health Care Medical Device Pharmaceutical
Founded:
2002-01-01
Address:
Las Vegas, Nevada, United States
Country:
United States
Website Url:
http://www.esppharma.com
Total Employee:
51+
Status:
Active
Contact:
(732)650-1377
Email Addresses:
[email protected]
Total Funding:
44 M USD
Technology used in webpage:
Domain Not Resolving Euro Apple Mobile Web App Capable Pound Sterling Google Analytics Classic Apple Mobile Web App Status Bar Style OSS CDN Mobile Optimized
Similar Organizations
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Advisors List
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series B - ESP Pharma
Apax Partners
Apax Partners investment in Series B - ESP Pharma
Domain Associates
Domain Associates investment in Series B - ESP Pharma
Thoma Cressey Equity Partners
Thoma Cressey Equity Partners investment in Series B - ESP Pharma
Official Site Inspections
http://www.esppharma.com
- Host name: 172.67.156.197
- IP address: 172.67.156.197
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ESP Pharma"
Leadership Team - CervoMed
John is a member of the board of directors of the Alliance for Aging Research (AAR), a Washington, D.C. based non-profit organization dedicated to promoting innovation to address …See details»
Board of Directors - CervoMed
Sylvie Grégoire, PharmD Co-Founder . Dr. Grégoire is the co-founder of CervoMed (formerly known as EIP Pharma) and has served as a member of the company's board of directors …See details»
EIP Pharma and Diffusion Pharmaceuticals Announce Merger …
Mar 30, 2023 Combined company will pursue late-stage clinical development of oral neflamapimod for the treatment of dementia with Lewy bodies EIP Pharma to initiate in 2Q …See details»
EIP PHARMA, INC - LinkedIn
EIP PHARMA, INC Pharmaceutical Manufacturing Boston, Massachusetts 590 followers Advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseasesSee details»
EIP Pharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (617) 863-3751 EIP Pharma is a clinical stage therapeutics company that focuses on the development and commercialization of drug …See details»
ESP Pharma Inc - Company Profile and News - Bloomberg Markets
Company profile page for ESP Pharma Inc including stock price, company news, executives, board members, and contact informationSee details»
ESP Pharma - Crunchbase Company Profile & Funding
E Shop Pharmacy is a discount worldwide pharmacy fulfillment service. ESP Pharma is a hospital-focused pharmaceutical company, engages in acquiring and enhancing the marketing …See details»
EIP Pharma - Craft
Cambridge, MA HQ. United States. 210 Broadway #201. Boston, MA. United States. John Hancock Tower, 120 St James Ave #6017See details»
EIP Pharma Appoints Noel Donnelly as CFO - PR Newswire
Jul 8, 2019 EIP Pharma, Inc. (www.eippharma.com) is a private, Cambridge, MA-based company advancing CNS-focused therapeutics to benefit patients with neurodegenerative …See details»
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to ...
BOSTON, Nov. 7, 2019 /PRNewswire/ -- EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that the Division of Neurology Products of the U.S. …See details»
EIP Pharma and Diffusion Pharmaceuticals Announce Merger
Mar 30, 2023 For more information, please visit www.eippharma.com or engage with us on Twitter and LinkedIn. About Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc. is a …See details»
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b …
BOSTON, Aug. 14, 2023 /PRNewswire/ -- EIP Pharma Inc. ("EIP Pharma" or the "Company"), a privately held clinical-stage company focused on developing treatments for neurodegenerative …See details»
News and Events - CervoMed
Jan 18, 2023 April 3, 2023 . EIP Pharma Announces Presentation of Neuroimaging Data Exhibiting Potential Effects of Neflamapimod on Cholinergic Structure and Function at …See details»
EIP Pharma Announces Positive Phase 2 Results for ... - CervoMed
Boston, Mass., October 6, 2020 – EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that the Phase 2 AscenD-LB study in patients with …See details»
EIP Pharma Announces Positive Phase 2 Results for Neflamapimod …
BOSTON, Oct. 6, 2020 /PRNewswire/ -- EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that the Phase 2 AscenD-LB study in patients with …See details»
EIP Pharma Announces Presentation of Positive Clinical Trial
Boston, Mass., November 7, 2020 – EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today provided the full results of the Phase 2 AscenD-LB study in …See details»
EIP Pharma Closes $11.2 Million Financing Round to Advance …
CAMBRIDGE, Mass., April 15, 2019 /PRNewswire/ -- EIP Pharma, a CNS-focused therapeutics company, announced today the successful completion of $11.2 million in new private funding …See details»
EIP Pharma Announces New Data Presentations from Phase 2
Nov 4, 2021 Final results of the AscenD-LB clinical study informs on disease-modifying potential of neflamapimod in dementia with Lewy bodies Presentations at 14th Clinical Trials in …See details»
EIP Pharma Announces Clinical Study Presentations at the 11th …
Oct 24, 2018 EIP Pharma, Inc. (www.eippharma.com) is a private, Cambridge, MA-based company advancing CNS-focused therapeutics for improved patient benefit. For more …See details»
EIP Pharma Announces Presentation of Positive Clinical Trial …
BOSTON, Nov. 7, 2020 /PRNewswire/ -- EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today provided the full results of the Phase 2 AscenD-LB study in …See details»